Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Epidemiology and pathophysiology of vascular thrombosis in acclimatized lowlanders at high altitude: A prospective longitudinal study.
Journal: The Lancet regional health. Southeast Asia
Published: June 29, 2023
The platinum coordination complex inhibits cell invasion-migration and epithelial-to-mesenchymal transition by altering the TGF-β-SMAD pathway in colorectal cancer.
Journal: Frontiers in pharmacology
Published: March 02, 2023
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells.
Journal: Journal for immunotherapy of cancer
Published: January 20, 2023
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Journal: Molecular cancer research : MCR
Published: September 30, 2022
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: April 06, 2022
Determination of anticancer potential of a novel pharmacologically active thiosemicarbazone derivative against colorectal cancer cell lines.
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: December 13, 2021
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment.
Journal: Oncogene
Published: December 07, 2021
Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating β‑catenin and increases irinotecan sensitivity in colorectal cancer.
Journal: International journal of oncology
Published: November 01, 2021
MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells.
Journal: Molecular cancer research : MCR
Published: August 13, 2021
Last Updated: 09/26/2026